With labs located in both Europe and the U.S., BioAgilytix provides global bioanalytical services for biomarkers, immunogenicity, PK, and cell-based assays supporting the development and release testing of biologics across multiple industries and disease states. Additionally, BioAgilytix boasts extensive experience analyzing gene therapy solutions across viral vectors, leveraging NAb assays to test for neutralizing activity against the vector of gene therapy. In our NEW Gene & Cell Therapy Web Center, our scientists share their expert perspectives on evolving methods and trends in cell & gene therapy bioanalysis. Speak with our experts today!